In these patients, canagliflozin may be considered to reduce MACE, based on drug-specific and patient factors [10]
Pos0687 a randomised dose ranging, placebo-controlled, phase II study assessing the efficacy and safety of Bi 655064, an antagonistic anti-Cd40 antibody, in patients with lupus nephritis
Similarly, the Huffington Post in September took Groupon to task for selling $18 tickets to New Yorks Metropolitan Museum of Art
Pillars for treating CKD The FLOW trial could lead to changes in how CKD and cardiometabolic diseases as a whole are treated
Nausea is both dose dependent and transient (short lived)
Pens que se estaba inventando la palabra", cuenta Diana, una usuaria de 23 aos que pide ser identificada solo por su nombre